126 related articles for article (PubMed ID: 30689580)
1. Lipidized Prolactin-Releasing Peptide Agonist Attenuates Hypothermia-Induced Tau Hyperphosphorylation in Neurons.
Pražienková V; Schirmer C; Holubová M; Železná B; Kuneš J; Galas MC; Maletínská L
J Alzheimers Dis; 2019; 67(4):1187-1200. PubMed ID: 30689580
[TBL] [Abstract][Full Text] [Related]
2. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.
Popelová A; Pražienková V; Neprašová B; Kasperová BJ; Hrubá L; Holubová M; Zemenová J; Blum D; Železná B; Galas MC; Kuneš J; Maletínská L
J Alzheimers Dis; 2018; 62(4):1725-1736. PubMed ID: 29614684
[TBL] [Abstract][Full Text] [Related]
3. Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.
Holubová M; Hrubá L; Popelová A; Bencze M; Pražienková V; Gengler S; Kratochvílová H; Haluzík M; Železná B; Kuneš J; Hölscher C; Maletínská L
Neuropharmacology; 2019 Jan; 144():377-387. PubMed ID: 30428311
[TBL] [Abstract][Full Text] [Related]
4. Anorexigenic lipopeptides ameliorate central insulin signaling and attenuate tau phosphorylation in hippocampi of mice with monosodium glutamate-induced obesity.
Špolcová A; Mikulášková B; Holubová M; Nagelová V; Pirnik Z; Zemenová J; Haluzík M; Železná B; Galas MC; Maletínská L
J Alzheimers Dis; 2015; 45(3):823-35. PubMed ID: 25624414
[TBL] [Abstract][Full Text] [Related]
5. Cellular Signaling and Anti-Apoptotic Effects of Prolactin-Releasing Peptide and Its Analog on SH-SY5Y Cells.
Zmeškalová A; Popelová A; Exnerová A; Železná B; Kuneš J; Maletínská L
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32882929
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of leptin and lipidized PrRP on metabolic pathways in ob/ob mice.
Kořínková L; Holubová M; Neprašová B; Hrubá L; Pražienková V; Bencze M; Haluzík M; Kuneš J; Maletínská L; Železná B
J Mol Endocrinol; 2020 Feb; 64(2):77-90. PubMed ID: 31855558
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
[TBL] [Abstract][Full Text] [Related]
8. Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration.
Maletínská L; Nagelová V; Tichá A; Zemenová J; Pirník Z; Holubová M; Špolcová A; Mikulášková B; Blechová M; Sýkora D; Lacinová Z; Haluzík M; Železná B; Kuneš J
Int J Obes (Lond); 2015 Jun; 39(6):986-93. PubMed ID: 25771926
[TBL] [Abstract][Full Text] [Related]
9. Lipidized PrRP Analog Exhibits Strong Anti-Obesity and Antidiabetic Properties in Old WKY Rats with Obesity and Glucose Intolerance.
Mráziková L; Hojná S; Vaculová P; Strnad Š; Vrkoslav V; Pelantová H; Kuzma M; Železná B; Kuneš J; Maletínská L
Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678151
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of lipidized analogs of prolactin-releasing peptide with a modified C- terminal aromatic ring.
Prazienkova V; Ticha A; Blechova M; Spolcova A; Zelezna B; Maletinska L
J Physiol Pharmacol; 2016 Feb; 67(1):121-8. PubMed ID: 27010901
[TBL] [Abstract][Full Text] [Related]
11. Prolactin-releasing peptide: a new tool for obesity treatment.
Kuneš J; Pražienková V; Popelová A; Mikulášková B; Zemenová J; Maletínská L
J Endocrinol; 2016 Aug; 230(2):R51-8. PubMed ID: 27418033
[TBL] [Abstract][Full Text] [Related]
12. The role of GLP-1/GIP receptor agonists in Alzheimer's disease.
Yu CJ; Ma D; Song LL; Zhai ZN; Tao Y; Zhang Y; Cai LY; Hou YH; Chen HY; Wang L
Adv Clin Exp Med; 2020 Jun; 29(6):661-668. PubMed ID: 32614526
[TBL] [Abstract][Full Text] [Related]
13. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.
Wu X; Kosaraju J; Tam KY
Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686
[TBL] [Abstract][Full Text] [Related]
14. Early intervention with glucagon-like peptide 1 analog liraglutide prevents tau hyperphosphorylation in diabetic db/db mice.
Ma DL; Chen FQ; Xu WJ; Yue WZ; Yuan G; Yang Y
J Neurochem; 2015 Oct; 135(2):301-8. PubMed ID: 26183127
[TBL] [Abstract][Full Text] [Related]
15. The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy.
Hansen HH; Barkholt P; Fabricius K; Jelsing J; Terwel D; Pyke C; Knudsen LB; Vrang N
Brain Res; 2016 Mar; 1634():158-170. PubMed ID: 26746341
[TBL] [Abstract][Full Text] [Related]
16. The Neuroprotective Effects of Justicidin A on Amyloid Beta25-35-Induced Neuronal Cell Death Through Inhibition of Tau Hyperphosphorylation and Induction of Autophagy in SH-SY5Y Cells.
Gu MY; Kim J; Yang HO
Neurochem Res; 2016 Jun; 41(6):1458-67. PubMed ID: 26887582
[TBL] [Abstract][Full Text] [Related]
17. Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures.
Zheng WH; Bastianetto S; Mennicken F; Ma W; Kar S
Neuroscience; 2002; 115(1):201-11. PubMed ID: 12401334
[TBL] [Abstract][Full Text] [Related]
18. Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study.
Mikulášková B; Holubová M; Pražienková V; Zemenová J; Hrubá L; Haluzík M; Železná B; Kuneš J; Maletínská L
Nutr Diabetes; 2018 Jan; 8(1):5. PubMed ID: 29339795
[TBL] [Abstract][Full Text] [Related]
19. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
[TBL] [Abstract][Full Text] [Related]
20. Repeated peripheral administration of lipidized prolactin-releasing peptide analog induces c-fos and FosB expression in neurons of dorsomedial hypothalamic nucleus in male C57 mice.
Pirník Z; Kolesárová M; Železná B; Maletínská L
Neurochem Int; 2018 Jun; 116():77-84. PubMed ID: 29601847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
